Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/1999
03/04/1999WO1999010476A1 Immunity enhancing lactic acid bacteria
03/04/1999WO1999010475A2 Attenuated strains of mycobacteria
03/04/1999WO1999010382A1 Peptides which elicit cytotoxic t cellular immunity
03/04/1999WO1999010379A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use
03/04/1999WO1999010375A2 Vaccine against hpv
03/04/1999WO1999010372A1 Molecular mimetics of meningococcal b epitopes
03/04/1999WO1999010364A1 Follistatin-3
03/04/1999WO1999010012A1 NOVEL priA
03/04/1999WO1999010009A1 A process for inhibiting complement activation via the alternative pathway
03/04/1999WO1999010008A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient
03/04/1999WO1999010007A1 Methods and compositions for enhanced wound healing
03/04/1999WO1999010005A1 Vaccines for chlamydia psittaci infections
03/04/1999WO1999009956A1 Rapid release encapsulated bioactive agents for inducing or potentiating an immune response and methods of using thereof
03/04/1999WO1998055626A3 Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
03/04/1999WO1998055607A3 Tumor targeted vector
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999CA2654522A1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as exipient
03/04/1999CA2316412A1 Attenuated strains of mycobacteria
03/04/1999CA2302525A1 Follistatin-3
03/04/1999CA2302317A1 A process for inhibiting complement activation via the alternative pathway
03/04/1999CA2301879A1 Tuberculosis vaccine
03/04/1999CA2301840A1 Peptides which elicit cytotoxic t cellular immunity
03/04/1999CA2301660A1 Adipocyte-specific protein homologs
03/04/1999CA2300370A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899339A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
03/03/1999EP0899337A2 FtsY polynucleotides and polypeptides of Stapyloccoccus aureus belonging to the signal recognition protein family
03/03/1999EP0899336A2 Streptococcus pneumoniae spoIIIE protein
03/03/1999EP0899335A2 MurB gene from Staphylococcus aureus
03/03/1999EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899330A1 Polypeptide isolated from the epidermis and its use
03/03/1999EP0899329A2 DextranaseB gene from Streptococcus pneumoniae
03/03/1999EP0898969A2 Neospora vaccine
03/03/1999EP0898578A1 STREPTOCOCCUS PNEUMONIAE TYROSYL-tRNA SYNTHETASE
03/03/1999EP0898577A1 STREPTOCOCCUS PNEUMONIAE METHIONYL tRNA SYNTHETASE
03/03/1999EP0673420B1 Mammalian receptors for interleukin-10 (il-10)
03/03/1999EP0620850B1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines
03/03/1999EP0616537B1 CDw52-SPECIFIC ANTIBODY FOR TREATMENT OF MULTIPLE SCLEROSIS
03/03/1999EP0595798B1 Bispecific heteroantibodies with dual effector functions
03/03/1999EP0565590B1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE)
03/03/1999EP0563288B1 Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
03/03/1999EP0537276B1 Cancer-associated scm-recognition factor, preparation and method of use
03/03/1999CN1209876A Isolated tyrosinase derived peptides and uses thereof
03/03/1999CN1209841A Biologically active and particularly peptide molecules having potentiating effect on growth hormone biological activity
03/03/1999CN1209840A Noval CREBa phenogen
03/03/1999CN1209837A Rotavirus antigens, vaccines and diagnostic drugs for infection with rotavirus and process for producing same
03/03/1999CN1209747A Modulation of TH1/TH2 cytokine expression by Ribavirin and Ribavirin analogs in activated T-lymphocytes
03/03/1999CN1209455A DNA of encoding plasminogen excited protein
03/03/1999CN1209340A Curative vaccinum for hepatitis B and preparing method therefor
03/03/1999CA2242313A1 Signal recognition particle polypeptides and polynucleotides
03/02/1999US5877305 DNA encoding biosynthetic binding protein for cancer marker
03/02/1999US5877302 Compacted nucleic acids and their delivery to cells
03/02/1999US5877298 Acellular pertussis vaccines and methods of preparing thereof
03/02/1999US5877296 Reacting disulfide analogs of calicheamicin family with a carrier such as protein, peptide, mono and polyclonal antibodies, their antigen-recognizing fragments and chemically or genetically engineered counterparts
03/02/1999US5877294 Antigenic regions of tumor-liberated particles (TLP) complexes and antibodies against the same
03/02/1999US5877293 CDR grafted anti-CEA antibodies and their production
03/02/1999US5877290 Humanized antibody fragment that binds a polypeptide sequence encoded by cdna of an anti-hypercalcemic hormone; treatment of electrolyte disorders, kidney failure, bone and heart disorders, osteoporosis, paget's disease
03/02/1999US5877285 Lymphocyte specific chemokines; for diagnostic kits; antiproliferative agents; anticancer agents; autoimmune disorders
03/02/1999US5877273 Antigenic polypeptide mycobacteria; for production of antibodies; for simple diagnosis of tuberculosis and leprosy
03/02/1999US5877159 The gene may encode, e.g., a vaccine antigen, an therapeutic agent, an immunoregulatory agent or a anti-sense rna or a catalytic rna.
03/02/1999US5877016 Human trk receptors and neurotrophic factor inhibitors
03/02/1999US5876997 Phytase
03/02/1999US5876985 Methods and compositions for the preparation of recombinant Trichomonas vaginalis proteins and peptides
03/02/1999US5876973 Method for making antibodies which specifically bind to glial growth factors
03/02/1999US5876972 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation
03/02/1999US5876969 Fusion polypeptide of therapeutic polypeptides attatched to c-and n-terminals of human serum albumin; for high plasma stability, minimization of dosage, side effect reduction
03/02/1999US5876967 Fibroblast growth factor homologous factor-2 and methods of use
03/02/1999US5876966 Compounds and methods for the stimulation and enhancement of protective immune responses and IL-12 production
03/02/1999US5876965 Nucleic acid encoding ARF-19, a novel regulator of the mammalian cell cycle
03/02/1999US5876962 Expression vectors for the synthesis of proteins and plasmid replicons and sequence cassettes for use in constructing such vectors
03/02/1999US5876961 Production of antibodies
03/02/1999US5876943 Antigenic polypeptide produced by genetic engineering for use in diagnosis of and vaccines to peptic ulcers and stomach cancer
03/02/1999US5876931 Identification of genes
03/02/1999US5876923 Screening suppressors which inhibit infected cell protein-4 polypetide by infecting cells with defective alpha-4 gene virus, incubating with compound allowing viral replication, comparing cell pathology
03/02/1999US5876919 Incubating compound with tub protein in vitro, detection of complex formed; for modulators of obesity, cachexia, and other eating disorders
03/02/1999US5876735 Methods for enhancement of protective immune responses
03/02/1999US5876733 Complexing
03/02/1999US5876732 Envelope protein
03/02/1999US5876731 Candidate vaccines against hiv-1 and which are useful in diagnostic application.
03/02/1999US5876727 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
03/02/1999US5876726 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
03/02/1999US5876725 Actinobacillus pleuropneumoniae transferrin binding protein vaccines and uses thereof
03/02/1999US5876724 Induction of neutralizing antibody against viral infection by synergy between virus envelope glycoprotein and peptides corresponding to neutralization epitopes of the glycoprotein
03/02/1999US5876723 Purified human papillomavirus type 33 (HPV-33) peptides as an immunogenic composition
03/02/1999US5876721 Vaccines
03/02/1999US5876718 Using antibodies which bind to protein
03/02/1999US5876717 Prevent rejection of organ transplantation and also to cure autoimmune diseases.
03/02/1999US5876712 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/02/1999US5876708 Allogeneic and xenogeneic transplantation
03/02/1999US5876691 Screening a bacteriophage library; diagnosis of colorectal tumors
03/02/1999CA2242315A1 Mecb
03/02/1999CA2242252A1 Dexb
03/02/1999CA2241417A1 Novel ffh
03/02/1999CA1340417C Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same
03/02/1999CA1340414C Inactivation of human immunodeficiency virus (hiv) in protein-containing solutions by phenols
1 ... 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 ... 1823